News

A paper has described how exosomes released by tumors manipulate the tumor microenvironment to favor metastasis.

Plants used by the indigenous population in Australia, the Aboriginal people, may be able to help cancer patients who are no longer susceptible to treatment with chemotherapy.

A team of scientists has developed a new synthetic hydrogel organoid as a prostate cancer model.

According to a clinical trial report, the combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation.

Endocrine disrupting chemicals (EDCs) can lead to certain forms of cancer. But exactly how certain compounds interfere with hormone binding to the receptor is not always easy to decipher. Researchers have developed a new live-cell quantitative analysis of ER dynamics.

Moles and melanomas are both skin tumors that come from the same cell called melanocytes. The difference is that moles are usually harmless, while melanomas are cancerous and often deadly without treatment. A researcher has explained how these skin tumors form and why moles can change into melanoma.

A biochemist has been awarded a grant to study how mRNA eraser enzymes work and how they can go wrong and lead to cancer.

A recent study has discovered that the expression of an allergy-related receptor chain for proinflammatory IL-13 cytokine protects against experimental skin cancer.

There are no established biomarkers to predict the success of immunotherapy in patients with liver cancer. A score based on simple laboratory parameters has now been developed to predict outcome in liver cancer patients receiving immunotherapy.

Prof. Michelle Farkas from the University of Massachusetts Amherst has been awarded a grant by the National Institutes of Health to develop next-generation tools to track and manipulate circadian rhythms in cancer cells.